Enter your terms above and click the 'Search' button.

Showing articles 0 to 8 of 8 Filter Applied: immune-related adverse events (Click to remove) Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies Neurol 92:663-674, Johansen, A.,et al, 2019 Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer Neurol 91:e985-e994, Touat, M.,et al, 2018 Neuroimaging Findings in Children and Young Adults with Neurotoxicity after CAR T-Cell Therapy for B-Cell Malignancies Neurol 105:e214086, McGuire,J.L.,et al, 2025 Confused About Confusion NEJM 386:80-87, Spanjaart, A.M.,et al, 2022 Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions Ann Neurol 89:1255-1256, Lambert, N.,et al, 2021 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 Acute demyelinating polyneuropathy induced by nivolumab JNNP 89:435-437, Fukumoto, Y.,et al, 2018 Showing articles 0 to 8 of 8